New ETF Book by Larry Connors - Click here to read more
The CX-1 is the Company's first fully hybrid digital retinal camera with both mydriatic and non-mydriatic modes. With one-touch, the operator can automatically switch between mydriatic and non-mydriatic modes, effortlessly utilizing different functions within seconds and performing several concurrent ocular tests.
"Canon continues to provide ophthalmologists with the latest digital imaging technology, allowing eyecare professionals to continue to provide comprehensive, high-end care to their patients," said Tsuneo Imai, senior director and general manager, Medical Systems Division, Canon U.S.A." At AAO, ophthalmologists will witness how the CX-1 Mydriatic/Non-Mydriatic Hybrid Digital Retinal Camera can play a significant role in helping them to efficiently operate their practices."
The Canon CX-1 allows the user to take one-shot FAF (Fundus Autofluorescence) photography, in a standard configuration, for both mydriatic and non-mydriatic modes. Detecting Autofluorescence of the retina is an important indication of the retina's health. Using the non-mydriatic mode not only saves time and resources, it also can make the diagnostic procedure more comfortable for the patient.
Canon's EOS camera technology, with its renowned image processing capabilities, has been adapted exclusively for medical use in the CX-1, providing up to 15.1-megapixel resolution. The CX-1 is capable of delivering clear and detailed diagnostic images for virtually immediate review. The single onboard digital camera handles five different photography modes with ease, including FAF, Color, Red-Free, Cobalt and Fluorescein Angiography photography.
The Retinal Imaging Control Software that comes with the CX-1 puts tools for image capture controls and easy viewing at a users fingertips. The intuitive graphical interface is simple and straightforward to use. The DICOM-compliant network interface allows easy integration with existing medical imaging systems and connection to PACS and HIS network configurations.
Also on display, Canon will demonstrate the synergy between the Company's retinal camera systems and Optical Coherence Tomography (OCT) products from OPTOPOL Technology S.A. OPTOPOL Technology S.A. SPOCT High Resolution(2) (HR) provides ultra-high resolution which can help give the doctor more comfort in diagnosis. Optical Coherence Tomography ultra-high scanning speeds shorten data collecting times and help to improve comfort of examination for patient and operator. The SPOCTHR has three micron axial resolution which, when combined with advanced analysis algorithm, makes SPOCTHR state-of-the art in SPOCT technology. Also showcased will be the OPTOPOL Technology S.A. SPOCT, which allows for non-invasive cross sectional imaging of the retina, while providing true, fast, 3D-imaging. The automated perimeter PTS 1000(3) from OPTOPOL Technology S.A will also be featured. The PTS 1000 is a diagnostic instrument that offers precise and fast testing of the field of vision. It features a wide range of strategies and analysis tools combined with intuitive interface, providing retinal specialists with a powerful diagnostic tool.
Integrating Digital Imaging Technology and Workflow Management for the Ophthalmic World
Canon offers and markets a full line of digital imaging solutions for the ophthalmic world, including Non-Mydriatic and Mydriatic Digital Retinal Cameras, Full Auto-Tonometer and Full Auto-Ref Keratometers, and image management software, all of which will be on display at the show. The Canon product line includes:
-- CF-1 Digital Mydriatic Retinal Camera, when attached to a Canon EOS Digital SLR Camera (sold separately), providing up to 15.1-megapixel resolution, is capable of delivering clear and detailed diagnostic images for virtually immediate review and offers outstanding operability. The CF-1 offers exceptional ease of use and an ergonomic, streamlined design which achieves improved operation by motorizing most procedures usually performed by hand.
-- CR-1 Mark II Digital Non-Mydriatic Retinal Camera reduces brightness, helps improve overall patient comfort and significantly shortens exams. When attached to a Canon EOS Digital SLR Camera (sold separately), providing up to 15.1-megapixel resolution, is capable of delivering clear and detailed diagnostic images for virtually immediate review. The low flash intensity of the Canon CR-1 Mark II minimizes miosis, thus shortening the time required for taking multiple pictures. High-resolution diagnostic images are achieved at a 45deg angle of view suitable for health check-ups and screening.
-- imageSPECTRUM Image Management Soft ware (Version 4.0) is the Canon imaging software for eyecare professionals, designed for use with the Canon CF-1 Digital Mydriatic Retinal Camera, the Canon CR-1 Mark II Digital Non-Mydriatic Retinal Camera and the Canon CX-1 Mydriatic/Non-Mydriatic Hybrid Digital Retinal Camera. Available for use with windows XP and windows Vista, imageSPECTRUM Image Management Software delivers capabilities that enhance patient care, including intelligent, efficient management of images with the reliability of Canon brand. The easy-to-use interface can be used as a standalone workstation or as part of network station.
-- RK-F1 Full Auto Ref-Keratometer allows for extremely easy operation with full automatic alignment for refractometry and keratometry, using the Full Auto Mode. With a press of the Start button, the RK-F1 automatically completes the entire series of steps for both eyes: alignment, measurement and printout.
-- TX-F Full Auto Tonometer is a non-contact tonometer, using the Canon Full Auto technology. The TX-F tonometer using Canon 3D Auto alignment and extremely soft air puff allows doctors to perform simple eye exams efficiently and reliably and enhances patient comfort. Once the eye is located on the alignment screen, just press start.
For more information about Canon ophthalmic devices and solutions, please go to www.usa.canon.com/eye-care.
About Canon U.S.A., Inc.
Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions. Its parent company, Canon Inc. (NYSE:CAJ), a top patent holder of technology, ranked third overall in the U.S. in 2008+, with global revenues of US $45 billion, is listed as number four in the computer industry on Fortune Magazine's World's Most Admired Companies 2009 list, and is on the 2009 BusinessWeek list of "100 Best Global Brands." Canon U.S.A. is committed to the highest levels of customer satisfaction and loyalty, providing 100 percent U.S. based consumer service and support for all of the products it distributes. At Canon, we care because caring is essential to living together in harmony. Founded upon a corporate philosophy of Kyosei -- "all people, regardless of race, religion or culture, harmoniously living and working together into the future" -- Canon U.S.A. supports a number of social, youth, educational and other programs, including environmental and recycling initiatives. Additional information about these programs can be found at www.usa.canon.com/kyosei. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss.
(1)The CX -1 Mydriatic/Non-Mydriatic Hybrid Digital Retinal Camera is not currently for sales or lease in the United States. Pending 510(k) clearance by the FDA.
(2) OPTOPOL Technology S.A. SPOCT-HR is not currently for sales or lease in the United States. Pending 510(k) clearance by the FDA.
(3)OPTOPOL Technology S.A. PTS 1000 is currently not for sale or lease in the United States.
+Based on weekly patent counts issued by United States Patent and Trademark Office.
Specifications subject to change without notice.
All referenced product names, and other marks, are trademarks of their respective owners.
SOURCE: Canon U.S.A., Inc.
Canon U.S.A. Web site: http://www.usa.canon.com or For customer information: 1-800-970-7227 or Editorial: Canon U.S.A. Mike DeMeo, 516-328-4928 mdemeo@cusa.canon.com or Heather Hasay Dinolfo, 516-328-5111 hdinolfo@cusa.canon.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
